BCL2 and gastric cancer: In contrast, this miRNA inhibits cell proliferation and colony formation and induces apoptosis in gastric cancer by targeting CREB1[21] and reduces drug resistance in pancreatic cancer by inhibiting CYLD and BCL-2[22]–[23].